US Patent 10463749 Maytansinoid derivatives, conjugates thereof, and methods of use
Patent 10463749 was granted and assigned to Regeneron Pharmaceuticals on November, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+175 characters)
Article
Patent abstract
Provided herein are maytansinoid compounds, derivatives thereof, conjugates thereof, and methods of treating or preventing proliferative diseases with the same.
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
104637490
Date of Patent
November 5, 2019
0Patent Application Number
159071420
Date Filed
February 27, 2018
0Patent Citations Received
Patent Primary Examiner
Edits on 27 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
104637490
Date of Patent
November 5, 2019
0Patent Application Number
159071420
Date Filed
February 27, 2018
0Patent Citations Received
Patent Primary Examiner
Golden AI
Infobox
Patent Citations Received
Edits on 21 Sep, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 29 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10463749 Maytansinoid derivatives, conjugates thereof, and methods of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10463749
Date of patent
November 5, 2019
Patent application number
15907142
Date Filed
February 27, 2018
Patent primary examiner
Find more entities like US Patent 10463749 Maytansinoid derivatives, conjugates thereof, and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
